New Frontier Data, one of the leading analytics firms in the cannabis industry, recently published a 400-page research note titled "The Cannabis Industry Annual Report" looking at the state of legal marijuana markets for 2017.
The extensive document goes into a wide array of topics, from market growth projections and job creation, to legislative activity and international markets.
Benzinga had a chance to talk to the firm's founder and CEO, Giadha Aguirre De Carcer.
So, which topic is especially interesting or unique?
Marijuana Patents
"There was one topic that just blew me away!" she said, pointing to the fact that the cannabis plant had been registered in the U.S. Patent Office. There are two approved patents that could potential cover more than 50 percent of the strains in the market, the report read.
“That's the equivalent of patenting potatoes. To me, it's just mind boggling. This just proves the abysmal lack of knowledge and understanding around these very unique plants,” Ghiada said.
It’s important to understand that not all patents registered around the cannabis plant make no sense. Among the almost 400 patents that have been filed in relation to cannabis, marijuana, CBD or THC, there are some that seem to adequately protect intellectual property, like techniques for extracting oil or specific infusion formulations. However, patenting the plant itself, or a few characteristics present in a majority of the strains out there is where the problem lies.
What has happened is comparable to someone basically saying, “if a potato has more than 75 calories per 100 grams, and more than 25 percent vitamin C, then you have to pay a royalty to grow it or sell it.”
The Economic Impact Of Patents
If the patents for the cannabis plant remain in effect, anyone producing or retailing marijuana will see a negative impact of 10 to 15 percent on his or her margins, Giadha explained. Actually, cultivators’ margins have been shrinking over the past couple of years, she added. All a patent would do is further “narrow down the number of stakeholders in the cannabis industry, and erode the growth of the industry.”
“Furthermore, a patent expert has informed New Frontier Data that similar patents have been filed in Europe, suggesting that Biotech Institute is in the process of accumulating worldwide rights to a large swath of the cannabis plant ecosystem in anticipation of prohibition laws being lifted in the U.S. and key international markets,” the report concluded.
The world is still finding out a lot of things about the cannabis plant but, as the industry advances, we'll need to address the patents issue to keep the space inclusive.
More From Benzinga:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
